Therapeutic Advances in Pediatric Multiple Sclerosis

Pediatric-onset multiple sclerosis (POMS) is a chronic, immune-mediated disorder that affects the central nervous system in children and adolescents. Approximately 3–10% of MS patients have an onset that occurs before the age of 18. The vast majority of pediatric MS cases are characterized by a rela...

Full description

Saved in:

Bibliographic Details
Published in:	Children (Basel) Vol. 12; no. 3; p. 259
Main Authors:	Walsh, Rachel, Chitnis, Tanuja
Format:	Journal Article
Language:	English
Published:	Switzerland MDPI AG 20.02.2025 MDPI
Subjects:	B cells Children Clinical trials Development and progression Disease disease-modifying therapy Diseases EDSS Immunomodulators Induction therapy Interferon Multiple sclerosis Ofatumumab Pathogenesis Patients pediatric multiple sclerosis pediatric-onset multiple sclerosis (POMS) Pediatrics PIRA RAW Review United States Italy Mississippi RAW pediatric multiple sclerosis pediatric-onset multiple sclerosis (POMS) PIRA disease-modifying therapy EDSS
ISSN:	2227-9067, 2227-9067
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!